Original Research
Published on 19 Feb 2024
The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China
in Head and Neck Cancer
- 2,524 views
- 2 citations